ADVENT AD Podcast: Atopic Dermatitis: Understanding Bone Health & Growth in Pediatric Atopic Dermatitis

In this episode, Dr. Amy Paller and Dr. Lisa Swanson as they delve into the risk of low bone mineral density and impaired growth reported in pediatric atopic dermatitis and observed improvements in growth observed with advanced therapy, especially among children with shorter stature at baseline. ADVENT is a medical education non-promotional resource for healthcare professionals organized by Sanofi and Regeneron. Learn more at ADVENTprogram.com. This podcast is intended for healthcare professionals only. · Disclaimer: o This program is non-promotional and is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. o The speakers are being compensated and/or receiving an honorarium from Sanofi and Regeneron in connection with this program. o The content contained in this program was jointly developed by the speakers and Sanofi and Regeneron and is not eligible for continuing medical education (CME) credits. · Speaker disclosures: o Lisa Swanson, MD, FAAD, has served as an investigator for Arcutis, Castle, Organon, and Sun. Dr. Swanson has participated as a speaker for AbbVie, Arcutis, Galderma, Incyte, Johnson & Johnson, Lilly, Organon, Pelthos, Pfizer, Sanofi-Regeneron, and Verrica. In addition, she has served as a consultant and advisory board member for AbbVie, Almirall, Alphyn, Arcutis, Boehringer Ingelheim, Castle, Chiesi, Galderma, Incyte, Johnson & Johnson, Leo, Lilly, Organon, Pelthos, Pfizer, Sanofi-Regeneron, and Verrica. o Amy Paller, MD, MS, has served as an advisor and consultant and has received grant funding from AbbVie, Abeona, Aegerion Pharmaceuticals, Azitra, BioCryst, Boehringer Ingelheim, Bristol Myers Squibb, Castle Creek Biosciences, Catawba, Eli Lilly and Company, Galderma, Gilead, InMed Pharmaceuticals, Janssen, Krystal Biotech, LEO Pharma, Novartis, Regeneron, Sanofi/Genzyme, Seanergy (consultant with honorarium), TWi Biotechnology, and UCB. © 2026 Sanofi and Regeneron Pharmaceuticals, Inc. All Rights Reserved. MAT-GLB-2600170 – 1.0 – 07/2026 Course Descriptors: MAT-GLB-2604085 – 1.0 – 07/2026